Last reviewed · How we verify
M518101
M518101 is a topical agent developed for dermatological use, likely targeting inflammatory or proliferative skin conditions.
At a glance
| Generic name | M518101 |
|---|---|
| Also known as | vitamin D3, psoriasis treatment |
| Sponsor | Maruho Co., Ltd. |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
M518101 is an investigational compound in phase 3 development by Maruho Co., Ltd., a Japanese pharmaceutical company specializing in dermatology. Without disclosed mechanism details, the drug's exact molecular target and therapeutic pathway remain proprietary. Given Maruho's focus on dermatological treatments, M518101 is likely formulated for topical application to treat skin disorders.
Approved indications
Common side effects
Key clinical trials
- Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients (PHASE3)
- Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients (PHASE2)
- Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis (PHASE3)
- Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis (PHASE3)
- Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis (PHASE3)
- Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers (PHASE1)
- Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers (PHASE1)
- Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- M518101 CI brief — competitive landscape report
- M518101 updates RSS · CI watch RSS
- Maruho Co., Ltd. portfolio CI